ASH Highlights and Commentary: Myeloid Malignancies

Viviana Perez, APRN, FNP-C, of Moffitt Cancer Center, considers real-world outcomes presented at the 2024 ASH Annual Meeting of momelotinib, a JAK1/JAK2/ACVR1 inhibitor that has shown promise in treating myelofibrosis in patients with anemia.

Authors

Publication Details

Journal
Journal of the Advanced Practitioner in Oncology
Published
2025-03-25
DOI
https://doi.org/10.6004/jadpro.2025.16.2.5
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ASH Highlights and Commentary: Myeloid Malignancies

A. Pérez
Journal of the Advanced Practitioner in Oncology
Acute Myeloid Leukemia Research
article

ASH Highlights and Commentary: Myeloid Malignancies

A. Pérez
article en

Abstract

Viviana Perez, APRN, FNP-C, of Moffitt Cancer Center, considers real-world outcomes presented at the 2024 ASH Annual Meeting of momelotinib, a JAK1/JAK2/ACVR1 inhibitor that has shown promise in treating myelofibrosis in patients with anemia.

Journal of the Advanced Practitioner in OncologyVol. 16(2)
Openalex Percentile: Top 92%
Acute Myeloid Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ASH Highlights and Commentary: Myeloid Malignancies — A. Pérez · Journal of the Advanced Practitioner in Oncology (2025) | TGRS Research Map | TGRS